Core Lithium Corp. (fka CORX)

[Pennimon]

licencing agreement: Techalt, Inc. (Pink Sheets:TCLT) ("Techalt" or "Company") announced that it has finalized a licensing agreement to develop and market Stan’s Rodeo Ointment (“SRO”), a sports cream product that can accelerate the healing time for abrasions, lacerations, blisters and other open wounds to the skin, while diminishing the pain that often results from such injuries.

What specifically do you want to know? All you need to know is whether the rights are international or not. Since TCLT is further DEVELOPING the cream and MARKETING the cream is fairly safe to assume a group of lawyers would be hell bent on protecting their investment.

SRO has undergone "tabletop" manufacturing to state of the art, and accordingly to 3/20 pr is raising or HAS raised funds to obtain over the counter approval.

It should be FAIRLY safe to assume that both licencing and marketing rights should be international in scope. Notice the current manufacturer is not mentioned in rights whatsoever.

It is apparent however that the manufacturer has taken quite an interest in SRO and the booth at the tradeshow reflects an investment in SRO. What kind of investment we dont know at the time, but the interest shown at the convention should have something to do with it.

Having a stand alone 10 by 30 booth for SRO is a HUGE endorsement of the manufacturer as well as an investment. TCLT was to raise the money to get over the counter approval but what if the manufacturer was covering the costs?

That would then be a matter between tclt and the manufacturer. Stan's job now should be only that of a promoter, has most likely received a sizable cash award and a portion of sales or royalities.

I doubt very much you will get any information in the way of licencing agreements as it is somewhat confidential. The manufacturer of SRO has already shown investment into both licencing requirements of SRO to tclt and stepped into the shoes of a partner/investor of sorts.

All this JMHO. P.





Great minds board: http://www.investorshub.com/boards/board.asp?board_id=5388